The American Diabetes Association® (ADA) is seeking applications for the Editor-in-Chief position of Diabetes®, the ADA’s flagship research publication.
The appointment is for three years, with a possible two-year extension. Applicants are asked to nominate 12–15 Associate Editors to assist with the development and review of content published in the journal. The new Editor-in-Chief and Associate Editors will convene in the summer of 2021 to begin inviting articles and reviewing new submissions for the January 2022 and later issues.
Diabetes publishes original research about the physiology and pathophysiology of diabetes. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes are not published. Diabetes is a monthly publication.
The American Diabetes Association provides administrative and salary support to the Editor-in-Chief’s institution, as well as honoraria to the Editor-in-Chief and Associate Editors. The ADA maintains its own Editorial Office and staff to manage the peer-review system and process.
Interested parties should request an application form, which must be completed and returned by February 1, 2021. Curriculum vitae of the applicants for Editor and Associate Editors should be included. Please address correspondence to:
Christian Kohler
Associate Publisher, Scholarly Journal Publishing
American Diabetes Association
ckohler@diabetes.org